Angelini Pharma has been awarded the prestigious Best in Media Communication 2022 (BIC) certification for the second year in a row. This recognition comes after a rigorous audit process conducted by Eikon Strategic Consulting, aimed at scientifically and objectively measuring the results of the company's communication efforts.
The Best in Media Communication certification is granted to companies that have distinguished themselves through effective and innovative corporate communication and strategic use of media. Angelini Pharma underwent a careful evaluation by a jury of independent experts who analyzed various aspects, including message clarity, creativity, and overall impact of the communication.
"We are extremely proud to have received the BIC certification for the second consecutive year. This recognition signifies that we are doing well and our dedication is acknowledged and appreciated. In the historical period we are living in, effective communication is more important than ever, especially for a pharmaceutical company," says Daniela Poggio, Global Communications Executive Director at Angelini Pharma. "Acknowledgements like this motivate us to strive for even better results with enthusiasm and creativity, and to continue innovating in a regulated industry such as pharma. For us, effective communication means caring for people's health."